Search Results - "Stiff, P"

Management of the adverse effects associated with intravenous bisphosphonates by Tanvetyanon, T., Stiff, P.J.

“…Intravenous bisphosphonates are widely used to treat hypercalcemia and to reduce skeletal-related morbidity among cancer patients. However, serious…”
Get full text

Mucositis associated with stem cell transplantation: current status and innovative approaches to management by Stiff, P

“…Treatment-related morbidity, and in some cases, mortality, associated with autologous and allogeneic bone marrow transplantation has decreased in the past…”
Get full text

Ex vivo expansion of umbilical cord blood stem cells for transplantation : growing knowledge from the hematopoietic niche by HOFMEISTER, C. C, ZHANG, J, KNIGHT, K. L, LE, P, STIFF, P. J

“…Umbilical cord blood transplantation (UCBT) in adults is limited by the small number of primitive hematopoietic stem cells (HSC) in each graft, resulting in…”
Get full text

The role of body mass index in survival outcome for lymphoma patients: US intergroup experience by Hong, F., Habermann, T.M., Gordon, L.I., Hochster, H., Gascoyne, R.D., Morrison, V.A., Fisher, R.I., Bartlett, N.L., Stiff, P.J., Cheson, B.D., Crump, M., Horning, S.J., Kahl, B.S.

“…The role of body mass index (BMI) in survival outcomes is controversial among lymphoma patients. We evaluated the association between BMI at study entry and…”
Get full text

Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT) by STIFF, P. J, ERDER, H, BENSINGER, W. I, EMMANOUILIDES, C, GENTILE, T, ISITT, J, LU, Z. J, SPIELBERGER, R

“…Oral mucositis (OM) is a frequent complication of myeloablative therapy and HSCT. We evaluated the feasibility, reliability, and validity of a new patient…”
Get full text

Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers by Spielberger, Ricardo, Stiff, Patrick, Bensinger, William, Gentile, Teresa, Weisdorf, Daniel, Kewalramani, Tarun, Shea, Thomas, Yanovich, Saul, Hansen, Keith, Noga, Stephen, McCarty, John, LeMaistre, C. Frederick, Sung, Eric C, Blazar, Bruce R, Elhardt, Dieter, Chen, Mon-Gy, Emmanouilides, Christos

“…Oral mucositis can be a debilitating and dangerous adverse effect of the chemoradiation used to prepare patients for bone marrow transplantation. Palifermin, a…”
Get full text

SWOG 2114: A RANDOMIZED PHASE II TRIAL OF CONSOLIDATION THERAPY FOLLOWING CD19 CAR T‐CELL TREATMENT FOR RELAPSED/REFRACTORY LARGE B‐CELL OR GRADE IIIB FOLLICULAR LYMPHOMA by Hess, B., Li, H., Hossain, N., Beylergil, V., Sauter, C., Hamadani, M., Svoboda, J., Major, A., Kahl, B., Leonard, J. P, Smith, S., LeBlanc, M., Stiff, P., Friedberg, J. W

Get full text

3‐Year outcomes of adults with relapsed or refractory B‐cell acute lymphoblastic leukemia treated with brexu‐cel in ZUMA‐3 by age, prior therapies, and subsequent transplant by Shah, B. D., Cassaday, R. D., Park, J. H., Houot, R., Oluwole, O. O., Logan, A. C., Boissel, N., Leguay, T., Bishop, M. R., Topp, M. S., O’Dwyer, K. M., Baer, M. R., Schiller, G. J., Abedi, M., Minnema, M. C., Stiff, P., Zhou, L., Hadjivassileva, T., Khalid, R. Damico, Ghobadi, A. Armin

Get full text

A prospective investigation of cell dose in single-unit umbilical cord blood transplantation for adults with high-risk hematologic malignancies by Sobol, U, Go, A, Kliethermes, S, Bufalino, S, Rodriguez, T, Smith, S, Parthasarathy, M, Stiff, P

“…Umbilical cord blood (UCB) as an allogeneic transplant source is generally limited to units with pre-cryopreservation total nucleated cell (TNC) doses ⩾2.5 ×…”
Get full text

Comparison of early quality of life outcomes in autologous and allogeneic transplant patients by Garcia, C M, Mumby, P B, Thilges, S, Stiff, P J

“…The Functional Assessment of Cancer Therapy-Bone Marrow Transplant measures quality of life (QOL) in SCT patients. Prior reports found mixed results regarding…”
Get full text

Retrospective utility of bronchoscopy after hematopoietic stem cell transplant by HOFMEISTER, C. C, CZERLANIS, C, FORSYTHE, S, STIFF, P. J

“…Fiberoptic bronchoscopy with bronchoalveolar lavage (BAL) is thought to be the procedure of choice to evaluate pulmonary infiltrates in hematopoietic stem cell…”
Get full text

Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: risk factors, cytokine use and cost by BOEVE, S, STRUPECK, J, CREECH, S, STIFF, P. J

“…Inadequate stem cell mobilization is seen in approximately 25% of patients undergoing autotransplantation for hematologic malignancies. Remobilization…”
Get full text

A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma by Leonard, JP, Friedberg, JW, Younes, A, Fisher, D, Gordon, LI, Moore, J, Czuczman, M, Miller, T, Stiff, P, Cheson, BD, Forero-Torres, A, Chieffo, N, McKinney, B, Finucane, D, Molina, A

“…Background: Galiximab is a monoclonal antibody that targets CD80, a costimulatory molecule constitutively expressed on follicular and other lymphomas. Modest…”
Get full text

Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin’s lymphoma and multiple myeloma: results from the expanded access program by Shaughnessy, P, Uberti, J, Devine, S, Maziarz, R T, Vose, J, Micallef, I, Jacobsen, E, McCarty, J, Stiff, P, Artz, A, Ball, E D, Berryman, R, Dugan, M, Joyce, R, Hsu, F J, Johns, D, McSweeney, P

“…Before US regulatory approval, an expanded access program provided plerixafor to patients with non-Hodgkin’s lymphoma (NHL), Hodgkin’s lymphoma (HD) or…”
Get full text

A potential role for B cells in suppressed immune responses in cord blood transplant recipients by Beaudette-Zlatanova, B C, Le, P T, Knight, K L, Zhang, S, Zakrzewski, S, Parthasarathy, M, Stiff, P J

“…We evaluated immune reconstitution in 58 adults who received hematopoietic SCTs from allogeneic siblings (allosib), matched unrelated donors (MUD) or cord…”
Get full text

S256: TABELECLEUCEL FOR EBV‐DRIVEN POST‐TRANSPLANT LYMPHOPROLIFERATIVE DISEASE FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL OR SOLID ORGAN TRANSPLANT AFTER FAILURE OF RITUXIMAB ± CHEMOTHERAPY (ALLELE) by Prockop, S., Beitinjaneh, A., Choquet, S., Dahiya, S., Dinavahi, R., Farah, R., Gamelin, L., Ghobadi, A., Mehta, A., Nayak, P., Reshef, R., Satyanarayana, G., Stiff, P., Ye, W., Mahadeo, K. M.

Get full text

Predictors of non-compliance in autologous hematopoietic SCT patients undergoing out-patient transplants by Mumby, P B, Hurley, C, Samsi, M, Thilges, S, Parthasarathy, M, Stiff, P J

“…Non-compliance has received significant attention in medicine, yet few studies have examined its correlates in autologous hematopoietic SCT (AHSCT) patients…”
Get full text

P356: SUBGROUP ANALYSES OF KTE‐X19, AN ANTI‐CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T‐CELL THERAPY, IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY B‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B‐ALL) IN ZUMA‐3 by Shah, B. D., Cassaday, R. D., Park, J. H., Houot, R., Oluwole, O. O., Logan, A. C., Boissel, N., Leguay, T., Bishop, M. R., Topp, M. S., Tzachanis, D., O'Dwyer, K. M., Arellano, M. L., Lin, Y., Baer, M. R., Schiller, G. J., Subklewe, M., Abedi, M., Minnema, M. C., Wierda, W. G., DeAngelo, D. J., Stiff, P., Jeyakumar, D., Dong, J., Adhikary, S., Zhou, L., Schuberth, P. C., Kharabi Masouleh, B., Ghobadi, A.

Get full text

Allogeneic hematopoietic cell transplantation for metastatic breast cancer by Ueno, N T, Rizzo, J D, Demirer, T, Cheng, Y C, Hegenbart, U, Zhang, M-J, Bregni, M, Carella, A, Blaise, D, Bashey, A, Bitran, J D, Bolwell, B J, Elfenbein, G J, Fields, K K, Freytes, C O, Gale, R P, Lazarus, H M, Champlin, R E, Stiff, P J, Niederwieser, D

“…We reviewed 66 women with poor-risk metastatic breast cancer from 15 centers to describe the efficacy of allogeneic hematopoietic cell transplantation (HCT)…”
Get full text

High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients by Stiff, P J, Bayer, R, Kerger, C, Potkul, R K, Malhotra, D, Peace, D J, Smith, D, Fisher, S G

“…To examine the prognostic factors associated with prolonged progression-free survival (PFS) and overall survival (OS) in 100 consecutively treated women…”
Get more information